Use of Maltodextrins in the ERAS Preoperative Fasting Protocol in Pediatric Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-17
SponsorAzienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

About this trial

This monocentric prospective randomized controlled pilot study aims to evaluate the effectiveness of preoperative maltodextrin administration within an Enhanced Recovery After Surgery (ERAS) protocol in pediatric surgical patients. Children aged 3 to 8 years undergoing elective day surgery will be randomized 1:1 to receive either a maltodextrin-containing clear liquid or a non-sugared clear liquid before surgery. The study will assess preoperative anxiety, patient compliance, parental anxiety, oxidative stress markers, postoperative feeding tolerance, and postoperative recovery outcomes.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Pediatric patients aged 3 to 17 years

Patients undergoing elective surgery in a day surgery setting

Surgical procedure duration less than 60 minutes

Written informed consent signed by a parent or legal guardian

Disqualifiers

Maltodextrin intake within 3 hours before surgery

Allergy or intolerance to maltodextrins

Diabetes mellitus or other metabolic disorders potentially affecting study variables

Inadequate nutritional status based on body mass index (BMI)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Maltodextrin Clear Liquid

    Dietary supplement

    Administration of 125 mL of a clear liquid containing maltodextrins two hours before elective pediatric surgery as part of the ERAS preoperative fasting protocol.

  • Non-Sugared Clear Liquid

    Other intervention

    Administration of 125 mL of a non-sugared clear liquid (water, tea, or chamomile) two hours before elective pediatric surgery.

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: Maltodextrin GroupExperimental treatment 1 intervention
Group B: Control GroupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Preoperative anxiety measured by Modified Yale Preoperative Anxiety Scale (m-YPAS)

Evaluation of preoperative anxiety and agitation in pediatric surgical patients receiving maltodextrin-containing clear liquids compared with control patients receiving non-sugared clear liquids before elective surgery.

Time frame
20 to 30 minutes before surgery

Secondary outcomes

1

Postoperative pain assessed by Visual Analogue Scale (VAS)

Evaluation of postoperative pain using the Visual Analogue Scale (VAS) in pediatric patients after elective surgery.

Time frame
2 hours after surgery
2

Eligibility for discharge after surgery

Evaluation of the proportion of pediatric patients considered eligible for discharge 6 hours after elective surgery according to postoperative recovery and clinical conditions.

Time frame
6 hours after surgery
3

Evaluation of postoperative vomiting

Incidence of participants experiencing at least one episode of postoperative vomiting during the first 6 hours after surgery.

Time frame
Within 6 hours after surgery
4

Preoperative oxidative stress

Blood chemistry tests for the assessment of preoperative stress

Time frame
Immediately before surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.